Literature DB >> 17185041

Transient regulatory T-cells: a state attained by all activated human T-cells.

Vinodh Pillai1, Sterling B Ortega, C K Wang, Nitin J Karandikar.   

Abstract

CD4(+)CD25(+)FOXP3(+) regulatory T-cells (T(regs)) form an important arm of the immune system responsible for suppressing untoward immune responses. T(regs) can be thymically derived or peripherally induced, even from CD4(+)CD25(-)FOXP3(-) T-cells. FOXP3 expression and in vitro suppressive activity are considered unique hallmarks of this dedicated and stable lineage of regulatory cells. Here we show that virtually all human CD4(+)CD25(-)FOXP3(-) T-cells and CD8(+)CD25(-)FOXP3(-) T-cells attain a transient FOXP3(+)CD25(+) state during activation. In this state of activation, these cells possess the classic phenotype of T(regs), in that they express similar markers and inhibit in vitro proliferation of autologous CD4(+)CD25(-) T-cells. This state is characterized by suppressed IFN-gamma production and robust TNF-alpha and IL-10 production. Interestingly, the great majority of the activated cells eventually downregulate FOXP3 expression, with a concomitant drop in suppressive ability. Our results show that, in humans, FOXP3 expression and T(reg) functionality are not exclusive features of a stable or unique lineage of T-cells but may also be a transient state attained by almost all T-cells. These results warrant caution in interpreting human studies using FOXP3 and suppressive activity as readouts and suggest that attempts to induce "T(regs)" may paradoxically result in induction of effector T-cells, unless stability is confirmed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185041      PMCID: PMC1868523          DOI: 10.1016/j.clim.2006.10.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  52 in total

1.  11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity.

Authors:  S C De Rosa; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

2.  Interpreting flow cytometry data: a guide for the perplexed.

Authors:  Leonore A Herzenberg; James Tung; Wayne A Moore; Leonard A Herzenberg; David R Parks
Journal:  Nat Immunol       Date:  2006-07       Impact factor: 25.606

3.  A new "Logicle" display method avoids deceptive effects of logarithmic scaling for low signals and compensated data.

Authors:  David R Parks; Mario Roederer; Wayne A Moore
Journal:  Cytometry A       Date:  2006-06       Impact factor: 4.355

4.  Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.

Authors:  Hans-Jörg Epple; Christoph Loddenkemper; Desirée Kunkel; Hanno Tröger; Jochen Maul; Verena Moos; Erika Berg; Reiner Ullrich; Jörg-Dieter Schulzke; Harald Stein; Rainer Duchmann; Martin Zeitz; Thomas Schneider
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

Review 5.  Regulatory T-cell compartmentalization and trafficking.

Authors:  Shuang Wei; Ilona Kryczek; Weiping Zou
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

6.  Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation.

Authors:  L A Schubert; E Jeffery; Y Zhang; F Ramsdell; S F Ziegler
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

7.  FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints.

Authors:  D Cao; O Börjesson; P Larsson; A Rudin; I Gunnarsson; L Klareskog; V Malmström; C Trollmo
Journal:  Scand J Immunol       Date:  2006-06       Impact factor: 3.487

8.  Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2(-/-)gammac(-/-) mice.

Authors:  Nicolas Legrand; Tom Cupedo; Anja U van Lent; Menno J Ebeli; Kees Weijer; Thomas Hanke; Hergen Spits
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

9.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.

Authors:  Nabila Seddiki; Brigitte Santner-Nanan; Jeff Martinson; John Zaunders; Sarah Sasson; Alan Landay; Michael Solomon; Warwick Selby; Stephen I Alexander; Ralph Nanan; Anthony Kelleher; Barbara Fazekas de St Groth
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  121 in total

1.  Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3.

Authors:  Angelika Schmidt; Francesco Marabita; Narsis A Kiani; Catharina C Gross; Henrik J Johansson; Szabolcs Éliás; Sini Rautio; Matilda Eriksson; Sunjay Jude Fernandes; Gilad Silberberg; Ubaid Ullah; Urvashi Bhatia; Harri Lähdesmäki; Janne Lehtiö; David Gomez-Cabrero; Heinz Wiendl; Riitta Lahesmaa; Jesper Tegnér
Journal:  BMC Biol       Date:  2018-05-07       Impact factor: 7.431

2.  Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.

Authors:  Dat Q Tran; Heather Ramsey; Ethan M Shevach
Journal:  Blood       Date:  2007-07-20       Impact factor: 22.113

3.  Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity.

Authors:  Vinodh Pillai; Nitin J Karandikar
Journal:  Blood       Date:  2008-01-01       Impact factor: 22.113

Review 4.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 5.  Histone deacetylase inhibitors and transplantation.

Authors:  Ran Tao; Edwin F de Zoeten; Engin Ozkaynak; Liqing Wang; Bin Li; Mark I Greene; Andrew D Wells; Wayne W Hancock
Journal:  Curr Opin Immunol       Date:  2007-08-24       Impact factor: 7.486

6.  Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.

Authors:  Daniel J Powell; Aloisio Felipe-Silva; Maria J Merino; Mojgan Ahmadzadeh; Tamika Allen; Catherine Levy; Donald E White; Sharon Mavroukakis; Robert J Kreitman; Steven A Rosenberg; Ira Pastan
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

7.  Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis.

Authors:  Núria Alonso; María Jesús Martínez-Arconada; María Luisa Granada; Berta Soldevila; Ana Cantón; José Luis Mate; Anna Sanmartí; Eva María Martínez-Cáceres
Journal:  Endocrine       Date:  2009-03-17       Impact factor: 3.633

Review 8.  Inhibitory CD8+ T cells in autoimmune disease.

Authors:  Masakatsu Suzuki; Christine Konya; Jörg J Goronzy; Cornelia M Weyand
Journal:  Hum Immunol       Date:  2008-09-21       Impact factor: 2.850

9.  Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells.

Authors:  Michael H Albert; Xue-Zhong Yu; Thomas Magg
Journal:  Clin Immunol       Date:  2008-09-25       Impact factor: 3.969

10.  Regulation gone wrong: a subset of Sézary patients have malignant regulatory T cells.

Authors:  Rachael A Clark
Journal:  J Invest Dermatol       Date:  2009-12       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.